Health Insurance Giant’s Changing Fortunes UnitedHealth Group (NYSE:UNH) is the largest U.S. health insurer by market cap and revenue, and dominates the healthcare industry through its ...

UnitedHealth stock price has imploded in the past few months, making it one of the worst-performing companies in the S&P 500 Index ...

The incidence and prevalence of CTD-ILD in the US is most common among women and older individuals, affecting approximately 116,000 to 118,000 adults.

UnitedHealth's shares drop 40% in 2025 amid challenges, with mixed Q1 earnings and margin pressures ahead. Read why I rate ...

The Howard County Board of Education is suing Eli Lilly and Co., Novo Nordisk, CVS, United Health group and several other ...

UnitedHealth is scheduled to report its Q2 earnings on July 29th. Jim Cramer recommends against buying UNH shares until then.

Hardman Johnston Global Advisors, an investment management company, released its “Hardman Johnston Global Equity Strategy” first quarter 2025 investor letter.

Three high-profile CEO appointments underscore the evolving priorities of top organizations: The St. Louis-based health system saw its CEO, Joseph Impicciche, announce his retirement, putting the ...

Optum Rx officials said they now have eliminated reauthorization requirements for more than 140 chronic disease medications.

From new executive appointments to expanded AI tools, here are 10 updates to know on UnitedHealth Group’s Optum, the parent company of ASC chain SCA Health, that Becker’s has reported on in the first ...

Beginning on July 7, however, some hybrid employees in Minnesota, where the insurance giant is based, and Washington, D.C., ...

UnitedHealth Group’s Optum Rx will remove reauthorization requirements for more than 60 chronic disease medications on July 1.  The cuts are in addition to about 80 reauthorizations Optum Rx ...